law

A New Lawsuit Filed Against Zofra – A New Zofra Pregnancy Lawsuit

Los Angeles-based law firm, Loncar Associates is currently filing Zofra pregnancy lawsuits to ensure that all plaintiffs of Zofra related pregnancy defects get rightful compensation from the drug manufacturer, AstraZeneca. Zofran, or more popularly known as Ondansetron is a common prescription drug which are commonly prescribed for vomiting and nausea; women suffering from severe symptoms while pregnant are often prescribed this drug during the early months of pregnancy; some side effects of the drug have caused problems during pregnancy and they seek compensation for these issues.

The lawsuit was filed on behalf of the plaintiffs, who are still suffering from birth defects brought about by the use of Zofra during pregnancy. Since Zofra contains ethinyl estradiol and other synthetic hormones, it is responsible for the development of birth defects like cleft lip and palate in the newborn baby, heart problems in the newborn baby, mental retardation in the newborn baby and so on.

The lawsuit seeks compensation for the patients who have been affected by the side effects of Zofra during pregnancy. This drug was widely used by pregnant women in the United States and the European Union before it was banned in Europe because of possible harm to the unborn babies. However, this drug was not banned in the United States.

In spite of the ban, the lawsuits argue that Zofra was still being sold in the United States even after its use by pregnant women was banned. Due to the continued use of the drug, there was a significant increase in the number of pregnant women who had been exposed to Zofra during pregnancy.

The plaintiffs claim that the presence of the synthetic hormone Ethinylestradiol in the drug is responsible for the development of birth defects like cleft lip and palate in the newborn; therefore, Zofra cannot be considered to be safe when used during pregnancy. In addition, they claim that the drug was responsible for increasing the risks of preterm delivery and miscarriage; furthermore, it has been linked with the increased risk of Sudden Infant Death Syndrome (SIDS) and Sudden Infant Death Syndrome (SIDS). {SIDS) is a condition in which the newborn dies within a few hours or days of birth. SIDS is the second most common cause of death in the United States and a SIDS is defined as an infant’s death occurring within a few hours of its birth.

The plaintiffs argue that these risks are not compensated since the drug company, AstraZeneca, failed to follow the regulation set by the FDA on using this drug. Moreover, they argue that the drug was manufactured in such a way that the drugs affect the newborns by altering the brain chemistry in such a way that there is no possibility of the newborn surviving with or without the drug, which is known as “toxic drug interaction”.

Leave a Reply

Your email address will not be published. Required fields are marked *